Medical Management of Diabetes and Heart Disease - part 2 pps

... Report of the expert committee on the diagnosis and classification of diabetes melli- tus. Diabetes Care 20 01; 24 (suppl 1):S5–S20. 2. Wingard DL, Barrett-Cannor E. Heart disease and diabetes. In: Diabetes ... Diabe- tes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Bio...

Ngày tải lên: 14/08/2014, 07:20

... Inc. 27 0 Madison Avenue, New York, NY 10016 tel: 21 2- 6 9 6-9 000; fax: 21 2- 6 8 5-4 540 Eastern Hemisphere Distribution Marcel Dekker AG Hutgasse 4, Postfach 8 12, CH-4001 Basel, Switzerland tel: 4 1-6 1 -2 6 1-8 4 82; ... patients with type 2 diabetes and overt coro- nary artery disease are being randomized in a 2 ϫ 2 factorial design. One random- ization is to...

Ngày tải lên: 14/08/2014, 07:20

... 1998; 98 :22 27 22 34. 25 . Estacio RO, Jeffers BW, Hiatt WR, et al. The effect of nisoldipine as compared with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645–6 52. 26 . Fein ... to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE study. Diabetes Care 1996; 19: 122...

Ngày tải lên: 14/08/2014, 07:20

... 1988–1994. Diabetes Care 1988; 21 :518– 524 . 4. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in mi- norities in the United States. Ann Intern Med 1996; 125 :22 1 23 2. 5. The ... hemostasis: the Framingham Offspring Study. JAMA 20 00; 28 3 :22 1– 22 8. 117. Cefalu WT. Insulin resistance: Cellular and clinical concepts. Exp Biol Med 20 01; 22 6:13 26 ....

Ngày tải lên: 14/08/2014, 07:20

... 5–15 10 20 IDL 1.006–1.019 5–10 ϫ 10 6 25 –35 20 –50 20 –40 15 25 LDL 1.019–1.063 2. 3 ϫ 10 6 18 25 5–15 40–50 20 25 HDL 1.063–1 .21 1.7–3.6 ϫ 10 6 5– 12 5–10 15 25 20 –30 Density: g/dL; MW: daltons; diameter: ... concentra- tion of PAI-1 in blood in normal subjects. Both phenomena, hormonal (hyperin- sulinemia) and metabolic (hyperglycemia and hypertriglyceridemia) derange- m...

Ngày tải lên: 14/08/2014, 07:20

... (IRS-1 and IRS -2 ) , and activation of the phosphoinositol 3′ kinase (PI-3′-K) pathway. On the other hand, cell growth and differentiation are regu- lated primarily by the SHC, GRB -2 , and the MAP-kinase ... insulin resistant, and perhaps as many as 25 % of overweight/obese individuals are nor- 8 Detection and Diagnosis of Syndromes of Insulin Resistance and of Dia...

Ngày tải lên: 14/08/2014, 07:20

... patho- 146 Horton 21 . Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and non-insulin dependent type 2 diabetes mellitus. Am J Physiol 19 82; 24 3:E15– E30. 22 . Gray ... results from a case-control study. Am J Obstet Gynecol 1996; 174: 122 4– 122 9; discussion 122 9– 123 2. 56. Fogel RB, Malhotra A, Pillar G, Pittman SD, Dunaif A, White DP. Increa...

Ngày tải lên: 14/08/2014, 07:20

... time of restenosis, that is 3 to 4 months post-intervention. For long-term follow-up of 26 8 Peragallo-Dittko Table 3 Recommendations Regarding Diabetes and Smoking Assessment of smoking status and ... of insulin-treated diabetic patients with two-vessel disease was similar at 5 and 10 years for PTCA and CABG (22 ). In BARI, however, 7-year survival of diabetics with tw...

Ngày tải lên: 14/08/2014, 07:20

... 191–193 trandolapril, 194 Myocardial ischemia, 171 Myocardial revascularization, 22 3 22 4, 23 2 23 7 adjunctive therapy, 24 7 25 1 balloon angioplasty, 23 3 23 9 vs. CABG, 23 9 24 2 candidate selection, 23 3 25 1 glycemic ... 21 9– 22 4 management, 21 8 22 7 mechanisms underlying, 21 7 21 8 normal ejection fraction, 22 5 22 7 Consensus Development Conference on Insulin Resistance...

Ngày tải lên: 14/08/2014, 07:20